Results 111 to 120 of about 495,928 (201)

OsCERK1-Mediated Chitin Perception and Immune Signaling Requires Receptor-like Cytoplasmic Kinase 185 to Activate an MAPK Cascade in Rice.

Molecular Plant, 2017
Chao Wang, Gang Wang, Chi Zhang, Pinkuan Zhu, Huiling Dai, N. Yu, Zuhua He, Ling Xu, Ertao Wang   +8 more
semanticscholar   +1 more source

Mitogen-Activated Protein Kinases: Therapeutic Signaling Catalysts in Viral Immune Evasion. [PDF]

Pathogens
Khan MA, Khan MH, Allemailem KS.
europepmc   +1 more source

Avian coronaviruses induce inflammatory responses by activating p38/MAPK signaling and NLRP3/caspase-1 inflammasomes through sphingosine-1-phosphate receptor 1. [PDF]

Vet Res
Xiao H, Yu S, Li S, Xu Z, Chen J, Lai L, Lin Q, Ren T, Chen L.   +8 more
europepmc   +1 more source

P2X7 receptors promote atrial remodeling and atrial fibrillation susceptibility via reactive oxygen species-mediated mitogen-activated protein kinase signaling activation. [PDF]

J Cell Commun Signal
Zhang L, Zhu Y, Gu X.
europepmc   +1 more source

The Green MAPKs

Asian Journal of Plant Sciences, 2009
Kalaivani Nadarajah, Hasidah Mohd Sidek
openaire   +1 more source

Crosstalk between circRNAs and the MAPK signaling pathway in cancer progression. [PDF]

Discov Oncol
Zahedi M, Maghrebi-Ghojogh E, Ahangari F, Zamani Sani M, Mafi A, Hushmandi K, Olianasab SA, Daneshi S, Alimohammadi M, Khoshnazar SM, Farahani N, Hashemi M, Taheriazam A.   +12 more
europepmc   +1 more source

Cucurbitacin B Promotes Tumor Necrosis Factor Receptor 1 Ectodomain Shedding by Selectively Activating the Extracellular Signal-Regulated Kinase Signaling Pathway. [PDF]

Int J Mol Sci
Yarangsee P, Fukai I, Phol S, Kinugawa K, Kusagawa E, Miyake Y, Kataoka T.   +6 more
europepmc   +1 more source

Probenecid is a dual-acting antiviral/anti-inflammatory therapy for diverse respiratory viruses. [PDF]

Front Pharmacol
Tripp RA, Jones LP, Martin DE.
europepmc   +1 more source

Prolonged KRAS-MAPK Inhibition Induces Interferon Signaling That Promotes Cell State Transition and Confers Therapeutic Vulnerabilities. [PDF]

Cancer Res
Bulle A, Chen Y, Li H, Chen TH, Khawar IA, Li L, Wang Y, Liu P, Somani VK, Kurupi R, Geng Y, Pereye OB, Bansod S, Le SB, Ruzinova MB, Tran DD, Lim KH.   +16 more
europepmc   +1 more source

Combination of Selpercatinib and Trametinib Overcomes Resistance to RET Inhibitors in RET-Mutant Medullary Thyroid Carcinoma. [PDF]

JCO Precis Oncol
Milewski D, Fallatah A, Groff M, Rahmy A, Khan SR, Okafor C, Glassberg B, Chou HC, Heselmeyer-Haddad K, Wangsa D, Wangsa D, Kim Y, Isanogle K, Song Y, Zhang X, Thomas C, Difilippantonio S, Park JI, Wei JS, Hawley RG, Glod J, Khan J.   +21 more
europepmc   +1 more source